Analyst Consensus ?
ConsensusBuy40 ratings
Bullish2152.5%
Neutral1947.5%
Bearish00.0%
FN2 Earnings Intelligence
Air Products and Chemicals, Inc. (APD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 7, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| Argus Research | Buy | Buy | Maintain | Sep 9, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 1, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 21, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 2, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Nov 11, 2025 |
| Barclays | Overweight | Overweight | Maintain | May 2, 2025 |
| Redburn Atlantic | Neutral | Sell | Upgrade | Oct 25, 2024 |
| Vertical Research | Buy | Hold | Upgrade | Oct 7, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 5, 2024 |
| Deutsche Bank | Hold | Buy | Downgrade | Jul 22, 2024 |
| TD Cowen | Buy | Buy | Maintain | May 1, 2024 |
| Seaport Global | Neutral | Buy | Downgrade | Feb 6, 2024 |
| Societe Generale | Hold | Buy | Downgrade | Jan 12, 2023 |
| Berenberg | Hold | Hold | Maintain | Oct 12, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 19, 2022 |
| Atlantic Equities | Overweight | Neutral | Upgrade | May 25, 2022 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 9, 2021 |
| Susquehanna | Positive | Neutral | Upgrade | Jun 11, 2021 |
| HSBC | Hold | Hold | Maintain | Jun 3, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 5, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 8, 2020 |
| Keybanc | Overweight | Overweight | Maintain | Jul 9, 2019 |
| Bank of America | Neutral | Underperform | Upgrade | Apr 25, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Baird | Neutral | Outperform | Downgrade | Jan 30, 2017 |
| William Blair | Market Perform | Outperform | Downgrade | Oct 31, 2014 |
| BGC FInancial | Hold | Buy | Downgrade | May 20, 2014 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Jul 24, 2013 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Jul 24, 2013 |
| First Analysis | Equal Weight | Overweight | Downgrade | Jul 16, 2013 |
| Raymond James | Outperform | Outperform | Maintain | Jun 14, 2013 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 25, 2012 |
Upside is calculated against the persisted current price $307.11. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Analyst unavailable | $346 | $295.63 | +12.7% | Oct 15, 2026 |
| Barclays | Aleksey Yefremov | $353 | $283.87 | +14.9% | Oct 12, 2026 |
| UBS | Analyst unavailable | $305 | $277.57 | -0.7% | Oct 5, 2026 |
| Argus Research | Alexandra Yates | $329 | $297.71 | +7.1% | Sep 9, 2026 |
| Deutsche Bank | Analyst unavailable | $320 | $291.69 | +4.2% | Aug 3, 2026 |
| Morgan Stanley | Vincent Andrews | $320 | $292.52 | +4.2% | Aug 3, 2026 |
| Bernstein | James Hooper | $373 | $293.66 | +21.5% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $350 | $300.2 | +14.0% | Jul 31, 2026 |
| RBC Capital | Analyst unavailable | $358 | $301.31 | +16.6% | Jul 17, 2026 |
| Bernstein | Analyst unavailable | $345 | $297.29 | +12.3% | Jul 17, 2026 |
| Evercore ISI | Eric Boyes | $342 | $298.92 | +11.4% | Jul 10, 2026 |
| Bernstein | James Hooper | $344 | $302.18 | +12.0% | Jul 1, 2026 |
| Morgan Stanley | Vincent Andrews | $310 | $301.07 | +0.9% | May 5, 2026 |
| Deutsche Bank | Analyst unavailable | $315 | $297.76 | +2.6% | May 4, 2026 |
| Mizuho Securities | John Roberts | $345 | $302.95 | +12.3% | May 1, 2026 |
| BMO Capital | Analyst unavailable | $360 | $300.05 | +17.2% | May 1, 2026 |
| Berenberg Bank | Analyst unavailable | $350 | $291.81 | +14.0% | Apr 20, 2026 |
| Wells Fargo | Michael Sison | $325 | $290.48 | +5.8% | Mar 13, 2026 |
| BMO Capital | John McNulty | $282 | $274.48 | -8.2% | Feb 2, 2026 |
| UBS | Analyst unavailable | $285 | $271.53 | -7.2% | Feb 2, 2026 |
| Bernstein | James Hooper | $315 | $272.02 | +2.6% | Feb 2, 2026 |
| Wells Fargo | Michael Sison | $270 | $272.5 | -12.1% | Feb 2, 2026 |
| Wells Fargo | Michael Sison | $250 | $243.75 | -18.6% | Dec 19, 2025 |
| Mizuho Securities | Analyst unavailable | $290 | $246.38 | -5.6% | Dec 18, 2025 |
| UBS | Analyst unavailable | $250 | $243.68 | -18.6% | Dec 11, 2025 |
| Argus Research | Analyst unavailable | $265 | $239.96 | -13.7% | Dec 11, 2025 |
| Deutsche Bank | Analyst unavailable | $255 | $230.8 | -17.0% | Dec 10, 2025 |
| Wolfe Research | Chris Parkinson | $315 | $241.4 | +2.6% | Dec 8, 2025 |
| Mizuho Securities | Analyst unavailable | $300 | $256.86 | -2.3% | Nov 7, 2025 |
| UBS | Analyst unavailable | $350 | $272.95 | +14.0% | Oct 6, 2025 |
| Goldman Sachs | Analyst unavailable | $335 | $272.72 | +9.1% | Oct 1, 2025 |
| UBS | Joshua Spector | $324 | $277.62 | +5.5% | May 2, 2025 |
| UBS | Joshua Spector | $335 | $265.3 | +9.1% | Apr 15, 2025 |
| Mizuho Securities | John Roberts | $385 | $333.37 | +25.4% | Dec 2, 2024 |
| UBS | Joshua Spector | $375 | $278.23 | +22.1% | Nov 18, 2024 |
| BMO Capital | John McNulty | $350 | $313.8 | +14.0% | Nov 14, 2024 |
| Jefferies | Laurence Alexander | $364 | $285.5 | +18.5% | Oct 7, 2024 |
| Evercore ISI | Stephen Richardson | $365 | $285.5 | +18.8% | Oct 7, 2024 |
| Citigroup | Patrick Cunningham | $345 | $285.5 | +12.3% | Oct 7, 2024 |
| Barclays | Michael Leithead | $295 | $281.74 | -3.9% | Aug 5, 2024 |
| Vertical Research | Kevin McCarthy | $261 | $236.34 | -15.0% | May 1, 2024 |
| Barclays | Analyst unavailable | $295 | $262.64 | -3.9% | Aug 8, 2022 |
| Deutsche Bank | Analyst unavailable | $290 | $260.32 | -5.6% | Aug 5, 2022 |
| Wells Fargo | Analyst unavailable | $243 | $227.58 | -20.9% | Jul 18, 2022 |
| Mizuho Securities | Analyst unavailable | $286 | $238.06 | -6.9% | Jul 7, 2022 |
| Jefferies | Analyst unavailable | $257 | $239.29 | -16.3% | Jun 16, 2022 |
| Vertical Research | Kevin McCarthy | $335 | $297.5 | +9.1% | Jan 4, 2022 |
| Wolfe Research | Josh Silverstein | $331 | $289.87 | +7.8% | Dec 9, 2021 |
| Evercore ISI | Stephen Richardson | $330 | $292.58 | +7.5% | Dec 7, 2021 |
| Berenberg Bank | Anthony Manning | $320 | $310.72 | +4.2% | Nov 10, 2021 |
| Societe Generale | Peter Clark | $334 | $291.42 | +8.8% | Jun 22, 2021 |
| Susquehanna | Sandy Klugman | $350 | $293.8 | +14.0% | Jun 11, 2021 |
| HSBC | Sriharsha Pappu | $269 | $297.38 | -12.4% | Jun 3, 2021 |
| Morgan Stanley | Vincent Andrews | $335 | $286.68 | +9.1% | May 12, 2021 |
Track every rating change on APD the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.